Innova Vascular key facts
as of Oct 2026- Operatorof minimally invasive thrombectomy devices intended to remove clots in patients with venous thromboembolism, including pulmonary embolism and deep vein thrombosis.
- Innova Vascular is valued at approximately $50.5M as of Oct 2026, set at its later-stage round, Jun 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $24.0M across 4 recorded rounds; the latest was Early Stage VC ($10.0M) in May 2025.
- Notable investors include MedTech Innovator, SeedFolio, Black Diamond Ventures, GEO MedTech Ventures, Cardiovascular Systems.
- Innova Vascular has filed 4 Form Ds with the SEC, most recently Jul 2025 ($10.0M sold to 5 investors).
- Status: Privately Held (backing).
Valued at $50.5M at its later-stage round, Jun 2025. Nothing has traded since.
- ·Watch Innova Vascular: the Monday email on marks, rounds and moves
Innova Vascular funding rounds
4 roundsWho backs Innova Vascular
5Innova Vascular valuation
Innova Vascular was valued at $50.5 million at its later-stage round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Innova Vascular raised?
Innova Vascular has raised $24 million across 4 recorded rounds since 2021. The largest was a $5.7 million early-stage round in Mar 2024; the most recent was a $10 million early-stage round in May 2025.
Innova Vascular has filed 4 Form Ds with the SEC, most recently in Jul 2025 ($10 million sold to 5 investors).
Innova Vascular investors
5 investors are on record for Innova Vascular, including MedTech Innovator, SeedFolio, Black Diamond Ventures and GEO MedTech Ventures. The early-stage round in May 2025 drew 5 investors.
About Innova Vascular
Operatorof minimally invasive thrombectomy devices intended to remove clots in patients with venous thromboembolism, including pulmonary embolism and deep vein thrombosis. The company offers an aspiration catheter system and a clot retrieval system cleared for commercial use, enabling hospitals and interventional specialists to perform catheter-based clot removal procedures.
- Sector
- Healthcare
- HQ
- Irvine, CA, United States
- Founded
- 2018
- Employees
- 9
- Website
- innovavascular.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.